CTOR
Citius Oncology, Inc.
NASDAQ: CTOR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.88
+2.31% today
Updated 2026-04-30
Market cap
$77.43M
P/E ratio
—
P/S ratio
19.63x
EPS (TTM)
$-0.31
Dividend yield
—
52W range
$0 – $6
Volume
0.3M
Citius Oncology, Inc. (CTOR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-133.20%
ROE
-47.40%
ROA
-14.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-10113.00 | — | — | — |
| 2022 | $0.00 | $-10.87M | — | — | — |
| 2023 | $0.00 | $-12.70M | — | — | — |
| 2024 | $0.00 | $-21.15M | — | — | — |
| 2025 | $0.00 | $-24.76M | — | — | — |